[{"NetIncomeLoss_1_Q3_USD":-159.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"Assets_0_Q3_USD":584696.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0_Q3_USD":5000001.0,"OperatingCostsAndExpenses_2_Q3_USD":10349.0,"OperatingCostsAndExpenses_1_Q3_USD":159.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":12713750.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q3_shares":12713750.0,"PaymentsForRepurchaseOfWarrants_2_Q3_USD":11600000.0,"PreferredStockSharesOutstanding_0_Q3_shares":null,"Liabilities_0_Q3_USD":570045.0,"Cash_0_Q3_USD":1524449.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":24682.0,"NetCashProvidedByUsedInFinancingActivities_2_Q3_USD":25000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q3_USD":24682.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_Q3_pure":0.5,"ProceedsFromIssuanceOrSaleOfEquity_0_Q3_USD":480000000.0,"FederalDepositInsuranceCorporationPremiumExpense_2_Q3_USD":250000.0,"CommonStockValue_0_Q3_USD":null,"ProceedsFromIssuanceOfCommonStock_2_Q3_USD":25000.0,"EquityMethodInvestmentOwnershipPercentage_0_Q3_pure":1.0,"ShortTermBankLoansAndNotesPayable_0_Q3_USD":1500000.0,"PreferredStockValue_0_Q3_USD":null,"NetIncomeLoss_2_Q3_USD":-10349.0,"PreferredStockSharesIssued_0_Q3_shares":null,"OtherUnderwritingExpense_2_Q3_USD":17799250.0,"AdditionalPaidInCapital_0_Q3_USD":23620.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":386251.0,"LiabilitiesCurrent_0_Q3_USD":570045.0,"NetCashProvidedByUsedInOperatingActivities_2_Q3_USD":-318.0,"AffiliateCosts_2_Q3_USD":10000.0,"NotesPayableRelatedPartiesClassifiedCurrent_0_Q3_USD":183794.0,"IncreaseDecreaseInAccruedLiabilities_2_Q3_USD":null,"DebtInstrumentConvertibleConversionPrice1_0_Q3_USD":1.5,"DeferredCostsCurrent_0_Q3_USD":560014.0,"StockholdersEquity_0_Q3_USD":14651.0,"DeferredOfferingCosts_0_Q3_USD":560014.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q3_USD":0.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_Q3_pure":0.15,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":584696.0,"DeferredIncomeTaxExpenseBenefit_2_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-10349.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q3_USD":671034.0,"Ticker":"ME","CIK":"1804591","name":"VG ACQUISITION CORP.","OfficialName":"23andMe Holding Co. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1542593591.0","Country":"United States","Sector":"Health Care","Industry":"Precision Instruments","Market":"NASDAQ","SP500":"nan","filed":"20201116"}]